Small-molecule inhibitors such as ICCB-19 and apostatin-1 (Apt-1), which modulate TRADD activity, have demonstrated significant efficacy in inflammatory and tumor models [25,26,27]. The gene discussed is TRADD; the disease is neoplasm.